As of Nov 20
| -0.05 / -2.04%|
The 2 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 13.50, with a high estimate of 20.00 and a low estimate of 7.00. The median estimate represents a +462.50% increase from the last price of 2.40.
The current consensus among 2 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.